Koorosh Shahpasand

2.1k total citations · 1 hit paper
54 papers, 1.2k citations indexed

About

Koorosh Shahpasand is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Koorosh Shahpasand has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Physiology, 21 papers in Molecular Biology and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in Koorosh Shahpasand's work include Alzheimer's disease research and treatments (21 papers), Neuroscience and Neuropharmacology Research (10 papers) and Nanoparticles: synthesis and applications (9 papers). Koorosh Shahpasand is often cited by papers focused on Alzheimer's disease research and treatments (21 papers), Neuroscience and Neuropharmacology Research (10 papers) and Nanoparticles: synthesis and applications (9 papers). Koorosh Shahpasand collaborates with scholars based in Iran, United States and Qatar. Koorosh Shahpasand's co-authors include Mojtaba Falahati, Farnoosh Attar, Keivan Akhtari, Majid Sharifi, Anwarul Hasan, Falah Mohammad Aziz, Ali Akbar Saboury, Behnam Rasti, Bilal Ahamad Paray and Hossein Derakhshankhah and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Neuroscience.

In The Last Decade

Koorosh Shahpasand

52 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies

2025 64 citations Masoud Eslami, Mohsen Jahanshahi et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Koorosh Shahpasand Iran	18	427	242	220	171	150	54	1.2k
Gaurav Das India	20	368 0.9×	138 0.6×	89 0.4×	95 0.6×	161 1.1×	72	1.1k
Yi Jin China	29	828 1.9×	165 0.7×	167 0.8×	140 0.8×	223 1.5×	127	2.4k
Audra L. Clos United States	10	355 0.8×	488 2.0×	269 1.2×	36 0.2×	156 1.0×	13	1.6k
Barnaby C. H. May United States	23	1.1k 2.6×	310 1.3×	63 0.3×	95 0.6×	72 0.5×	54	2.1k
Mohammad S. Alavijeh United Kingdom	22	419 1.0×	66 0.3×	125 0.6×	42 0.2×	218 1.5×	50	1.5k
Giuseppe Palma Italy	27	1.1k 2.6×	139 0.6×	68 0.3×	87 0.5×	163 1.1×	88	2.2k
Xifeng Lu China	23	663 1.6×	139 0.6×	235 1.1×	110 0.6×	299 2.0×	54	1.7k
Seetha Harilal India	11	170 0.4×	103 0.4×	83 0.4×	36 0.2×	157 1.0×	20	655
Avinash Gothwal India	20	655 1.5×	208 0.9×	132 0.6×	20 0.1×	310 2.1×	31	1.7k

Countries citing papers authored by Koorosh Shahpasand

Since Specialization

Citations

This map shows the geographic impact of Koorosh Shahpasand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koorosh Shahpasand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koorosh Shahpasand more than expected).

Fields of papers citing papers by Koorosh Shahpasand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koorosh Shahpasand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koorosh Shahpasand. The network helps show where Koorosh Shahpasand may publish in the future.

Co-authorship network of co-authors of Koorosh Shahpasand

This figure shows the co-authorship network connecting the top 25 collaborators of Koorosh Shahpasand. A scholar is included among the top collaborators of Koorosh Shahpasand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koorosh Shahpasand. Koorosh Shahpasand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eslami, Masoud, Mohsen Jahanshahi, Ali Salami, et al.. (2025). Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies. Molecular Cancer. 24(1). 58–58. 64 indexed citations breakdown →

Shahpasand, Koorosh, et al.. (2024). cis P-tau Accumulation Triggers Neurodegeneration after Ischemic Stroke. ACS Omega. 9(5). 5509–5516. 4 indexed citations

Shahpasand, Koorosh, et al.. (2023). Intra-hippocampal cis-P tau microinjection induces long-term changes in behavior and synaptic plasticity in mice. Behavioral and Brain Functions. 19(1). 9–9. 2 indexed citations

Shekari, Faezeh, et al.. (2023). Clonal mesenchymal stem cell-derived extracellular vesicles improve mouse model of weight drop-induced traumatic brain injury through reducing cistauosis and apoptosis. Experimental Neurology. 367. 114467–114467. 7 indexed citations

Totonchi, Mehdi, Hossein Baharvand, Hossein Pakdaman, et al.. (2022). P38 initiates degeneration of midbrain GABAergic and glutamatergic neurons in diabetes models. European Journal of Neuroscience. 56(1). 3755–3778. 1 indexed citations

Mohammadnejad, Daryoush, et al.. (2022). Spinal Cord Injury Causes Prominent Tau Pathology Associated with Brain Post-Injury Sequela. Molecular Neurobiology. 59(7). 4197–4208. 4 indexed citations

Eslahchi, Changiz, et al.. (2022). Exploring the role of non-coding RNAs as potential candidate biomarkers in the cross-talk between diabetes mellitus and Alzheimer’s disease. Frontiers in Aging Neuroscience. 14. 955461–955461. 14 indexed citations

Eslahchi, Changiz, et al.. (2022). Identification of repurposed drugs targeting significant long non-coding RNAs in the cross-talk between diabetes mellitus and Alzheimer’s disease. Scientific Reports. 12(1). 18332–18332. 6 indexed citations

Tebianian, Majid, et al.. (2022). Active immunotherapy against pathogenic Cis pT231-tau suppresses neurodegeneration in traumatic brain injury mouse models. Neuropeptides. 96. 102285–102285. 6 indexed citations

10.

Kimura, Taeko, Tomoyasu Matsubara, Yuko Saito, et al.. (2021). Distinct phosphorylation profiles of tau in brains of patients with different tauopathies. Neurobiology of Aging. 108. 72–79. 19 indexed citations

11.

Shahpasand, Koorosh, et al.. (2020). Dopamine-loaded Poly (butyl cyanoacrylate) Nanoparticles Reverse Behavioral Deficits in Parkinson’s Animal Models. Therapeutic Delivery. 11(6). 387–399. 20 indexed citations

12.

Bonyadi, Mortaza, Mortaza Bonyadi, Hamid Ahmadieh, et al.. (2020). Association of Saitohin gene rs62063857 polymorphism with dry type age-related macular degeneration. Ophthalmic Genetics. 41(5). 505–506. 1 indexed citations

13.

Hasan, Anwarul, Behnam Rasti, Bilal Ahamad Paray, et al.. (2020). Exploring the Interaction of Cobalt Oxide Nanoparticles with Albumin, Leukemia Cancer Cells and Pathogenic Bacterial by Multispectroscopic, Docking, Cellular and Antibacterial Approaches. International Journal of Nanomedicine. Volume 15. 4607–4623. 35 indexed citations

14.

Sohrabi, Mohammad Javad, Ahmad Reza Dehpour, Farnoosh Attar, et al.. (2019). Silymarin-albumin nanoplex: Preparation and its potential application as an antioxidant in nervous system in vitro and in vivo. International Journal of Pharmaceutics. 572. 118824–118824. 25 indexed citations

15.

Aziz, Falah Mohammad, Abbas Salihi, Mahsa Ale‐Ebrahim, et al.. (2019). The interaction of silica nanoparticles with catalase and human mesenchymal stem cells: biophysical, theoretical and cellular studies. International Journal of Nanomedicine. Volume 14. 5355–5368. 10 indexed citations

16.

Kanavi, Mozhgan Rezaei, et al.. (2019). Pathogenic Tau Protein Species: Promising Therapeutic Targets for Ocular Neurodegenerative Diseases. Journal of Ophthalmic and Vision Research. 14(4). 491–505. 10 indexed citations

17.

Attar, Farnoosh, Fatemeh Rouhollah, Keivan Akhtari, et al.. (2019). Amorphous aggregation of tau in the presence of titanium dioxide nanoparticles: biophysical, computational, and cellular studies. International Journal of Nanomedicine. Volume 14. 901–911. 23 indexed citations

18.

Mohammadi, Alireza, Peiman Brouki Milan, Farshid Sefat, et al.. (2018). Transplantation of Human Chorion-Derived Cholinergic Progenitor Cells: a Novel Treatment for Neurological Disorders. Molecular Neurobiology. 56(1). 307–318. 9 indexed citations

19.

Behzadi, Elham, et al.. (2018). Albumin binding and anticancer effect of magnesium oxide nanoparticles. International Journal of Nanomedicine. Volume 14. 257–270. 65 indexed citations

20.

Akhtari, Keivan, et al.. (2018). Silica nanoparticles induce conformational changes of tau protein and oxidative stress and apoptosis in neuroblastoma cell line. International Journal of Biological Macromolecules. 124. 1312–1320. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact